Trial intelligence / Profile preview

Single-dose chewable mebendazole versus placebo for pediatric soil-transmitted helminth infections

2016-000728-24Phase 3

Sponsor
Janssen Pharmaceutical
Start
Mar 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in Soil-Transmitted Helminthiases (STH), ascariasis and trichuriasis comparing Mebendazole with Placebo (2 arms). Primary endpoint: Cure rate for A. lumbricoides.

02

Drugs

mebendazole
03

Conditions

Soil-Transmitted Helminthiases (STH)ascariasistrichuriasis

Beyond the preview

Go deeper on 2016-000728-24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-000728-24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call